Nanobiotix: Baillie Gifford & Co. below 5% of share capital
(CercleFinance.com) - On November 19, 2024, Baillie Gifford & Co.
, acting on behalf of clients and funds under its management, declared to the AMF that it had fallen below the threshold of 5% of the capital of Nanobiotix, and held 4.99% of the company's capital and 4.81% of its voting rights.
This threshold crossing results from the sale of Nanobiotix shares on the market.
Copyright (c) 2024 CercleFinance.com. All rights reserved.